Story thread · 2 reports / 2 sources
This Cambridge startup is building a ‘foundation model’ for the chest to speed drug trials
thenextweb.com · 13d
How the coverage leans
Across 2 sources · syndicated copies counted once
Most AI imaging startups build one model per disease. A Cambridge company has raised $20m to build a single model for the whole chest. Then it can spin the rest out of that. Qureight makes AI imaging tools for lung and heart clinical trials. It closed a $20m Series B led by Molten Ventures, the […] This story continues at The Next Web
First report: Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials — tech.eu, 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.